Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

The Role of ADAMTS-4 in Atherosclerosis and Vessel Wall Abnormalities (CROSBI ID 305732)

Prilog u časopisu | pregledni rad (znanstveni) | međunarodna recenzija

Novak, Ruđer ; Hrkač, Stela ; Salai, Grgur ; Bilandžić, Joško ; Mitar, Luka ; Grgurević, Lovorka The Role of ADAMTS-4 in Atherosclerosis and Vessel Wall Abnormalities // Journal of vascular research, 59 (2022), 2; 69-77. doi: 10.1159/000521498

Podaci o odgovornosti

Novak, Ruđer ; Hrkač, Stela ; Salai, Grgur ; Bilandžić, Joško ; Mitar, Luka ; Grgurević, Lovorka

engleski

The Role of ADAMTS-4 in Atherosclerosis and Vessel Wall Abnormalities

Extracellular matrix proteins are regulated by metzincin proteases, like the disintegrin metalloproteinases with thrombospondin motifs (ADAMTS) family members. This review focuses on the emerging role which ADAMTS-4 might play in vascular pathology, which has implications for atherosclerosis and vessel wall abnormalities, as well as for the resulting diseases, such as cardiovascular and cerebrovascular disease, aortic aneurysms, and dissections. Major substrates of ADAMTS-4 are proteoglycans expressed physiologically in smooth muscle cells of blood vessels. Good examples are versican and aggrecan, principal vessel wall proteoglycans that are targeted by ADAMTS-4, driving blood vessel atrophy, which is why this metzincin protease was implicated in the pathophysiology of vascular diseases with an atherosclerotic background. Despite emerging evidence, it is important not to exaggerate the role of ADAMTS-4 as it is likely only a small piece of the complex atherosclerosis puzzle and one that could be functionally redundant due to its high structural similarity to other ADAMTS family members. The therapeutic potential of inhibiting ADAMTS-4 to halt the progression of vascular disease after initialization of treatment is unlikely. However, it is not excluded that it might find a purpose as a biomarker of vascular disease, possibly as an indicator in a larger cytokine panel.

A disintegrin and metalloproteinase with thrombospondin motifs-4 ; Vascular disease ; Atherosclerosis ; Metalloproteinases

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

59 (2)

2022.

69-77

objavljeno

1018-1172

1423-0135

10.1159/000521498

Povezanost rada

Biotehnologija u biomedicini (prirodno područje, biomedicina i zdravstvo, biotehničko područje)

Poveznice
Indeksiranost